A top U.S. regulator is discrediting research published a year ago that found impurities in dozens of generic heart drugs made overseas, saying the investigators contaminated the samples during their testing. Preston Mason, lecturer on medicine at Brigham and Women’s Hospital, led the study.
News & Research
